
|Articles|February 23, 2004
P&T Portfolio: Abarelix
Abarelix injectable suspension (Plenaxis) is a treatment option for patients with advanced prostate cancer who have no alternative therapy.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
CMS Announces 15 New High-Cost Drugs for Medicare Price Negotiation Program
2
Work Pressure Continues to Impact Pharmacists’ Suicide Risk, Mental Health
3
Pharmacists Guide Patients as Prescription Drugs Move Over the Counter
4
Community Pharmacies Serve as Travel Vaccine and Information Hubs
5


















